Clearmind Medicine Common Stock Price on September 10, 2024
| CMND Stock | USD 1.33 0.10 6.99% |
If you're considering investing in Clearmind Stock, it is important to understand the factors that can impact its price. As of today, the current price of Clearmind Medicine stands at 1.33, as last reported on the 11th of December 2024, with the highest price reaching 1.33 and the lowest price hitting 1.33 during the day. At this point, Clearmind Medicine is extremely dangerous. Clearmind Medicine Common secures Sharpe Ratio (or Efficiency) of 0.0296, which signifies that the company had a 0.0296% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Clearmind Medicine Common, which you can use to evaluate the volatility of the firm. Please confirm Clearmind Medicine's risk adjusted performance of 0.0232, and Mean Deviation of 3.69 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%.
At present, Clearmind Medicine's Common Stock is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 5.2 M, whereas Other Stockholder Equity is forecasted to decline to about 1.6 M. . At present, Clearmind Medicine's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.51, whereas Price To Operating Cash Flows Ratio is projected to grow to (0.15). Clearmind Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Clearmind |
Sharpe Ratio = 0.0296
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.1 actual daily | 54 54% of assets are less volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Clearmind Medicine is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearmind Medicine by adding it to a well-diversified portfolio.
Price Book 1.6764 | Book Value 0.873 | Enterprise Value -1.8 M | Enterprise Value Ebitda (0.79) | Shares Float 3.6 M |
Clearmind Medicine Valuation on September 10, 2024
It is possible to determine the worth of Clearmind Medicine on a given historical date. On September 10, 2024 Clearmind was worth 1.37 at the beginning of the trading date compared to the closed value of 1.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Clearmind Medicine stock. Still, in general, we apply an absolute valuation method to find Clearmind Medicine's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Clearmind Medicine where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Clearmind Medicine's related companies.
| Open | High | Low | Close | Volume | |
| 1.27 | 1.37 | 1.27 | 1.37 | 94,229 | |
09/10/2024 | 1.37 | 1.38 | 1.32 | 1.33 | 52,442 |
| 1.32 | 1.33 | 1.29 | 1.30 | 85,565 |
| Backtest Clearmind Medicine | | | Clearmind Medicine History | | | Clearmind Medicine Valuation | Previous | Next |
Clearmind Medicine Trading Date Momentum on September 10, 2024
| On September 11 2024 Clearmind Medicine Common was traded for 1.30 at the closing time. The top price for the day was 1.33 and the lowest listed price was 1.29 . The trading volume for the day was 85.6 K. The trading history from September 11, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.26% . The overall trading delta against the current closing price is 5.26% . |
Clearmind Medicine Common Fundamentals Correlations and Trends
By evaluating Clearmind Medicine's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Clearmind Medicine's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Clearmind financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Clearmind Medicine Stock history
Clearmind Medicine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Clearmind is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Clearmind Medicine Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Clearmind Medicine stock prices may prove useful in developing a viable investing in Clearmind Medicine
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 232.9 K | 244.5 K | |
| Net Loss | -8.5 M | -8 M |
Clearmind Medicine Quarterly Net Working Capital |
|
Clearmind Medicine Stock Technical Analysis
Clearmind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Clearmind Medicine Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Clearmind Medicine Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Clearmind Medicine December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Clearmind Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearmind Medicine shares will generate the highest return on investment. By undertsting and applying Clearmind Medicine stock market strength indicators, traders can identify Clearmind Medicine Common entry and exit signals to maximize returns
Clearmind Medicine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Clearmind Medicine's price direction in advance. Along with the technical and fundamental analysis of Clearmind Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Clearmind to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0232 | |||
| Jensen Alpha | 0.1422 | |||
| Total Risk Alpha | (0.85) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.39) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |